CMC
Executive Summary
On July 19, the pharmaceutical science committee will provide comments to the Risk-based Chemistry, Manufacturing & Controls Review Working Group on the establishment of a list of low-risk drugs with respect to quality control (1"The Pink Sheet" Nov. 27, 2000, p. 24). The July 20 and 21 meetings begin at 8:30 a.m. in CDER's advisory committee room at 5630 Fishers Lane, Rockville, Md